The Role of Genetic Factors in the Development of Breast Cancer in the Kazakh Population
NCT05090605 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 700
Last updated 2023-03-14
Summary
This is a GWAS study that aims to identify possible candidate genes associate to breast cancer by exploring single nucleotide polymorphism (SNP) in a group of breast cancer, in the Kazakh population. The investigators hypothesize that the careful phenotyping of the subject sand matching with increase the power to find SNP significantly associate with breast cancer
Conditions
Interventions
- GENETIC
-
DNA analysis
GWAS
Sponsors & Collaborators
-
Asfendiyarov Kazakh National Medical University
lead OTHER
Principal Investigators
-
Dilyara Radikovna Kaidarova, M.D, Prof., Academician of the · JSC "Kazakh Institute of Oncology and Radiology", Almaty, Kazakhstan
-
Nazgul Omarbayeva, M.D / PhD · JSC "Kazakh Institute of Oncology and Radiology", Almaty, Kazakhstan
Eligibility
- Min Age
- 18 Years
- Max Age
- 60 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-03-30
- Primary Completion
- 2023-01-20
- Completion
- 2023-01-20
Countries
- Kazakhstan
Study Locations
More Related Trials
-
PTEN and Organ-Specific microRNAs in Metastatic Breast Cancer
NCT07297134 ·Status: RECRUITING
-
Cluster Randomized Trial Comparing Interventions to Enhance Genetic Counseling Among Breast Cancer Patients
NCT01789684 ·Status: COMPLETED ·Phase: NA
-
Pharmacogenetics of Anastrozole in Postmenopausal Women With Estrogen Receptor-Positive and/or Progesterone Receptor-Positive Stage I, Stage II, or Stage III Breast Cancer
NCT00283608 ·Status: COMPLETED
-
Celecoxib in Preventing Breast Cancer in At-Risk Premenopausal Women
NCT00056082 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Efficacy and Safety in Premenopausal Women With Hormone Receptor Positive, HER2-negative Advanced Breast Cancer
NCT02278120 ·Status: COMPLETED ·Phase: PHASE3
-
Genetic Counseling for Menopausal Therapy Decision-Making for Women at Increased Risk for Breast Cancer
NCT00349011 ·Status: COMPLETED ·Phase: NA
-
Study to Assess the Efficacy and Safety of the Epigenetic Modifying Effects of CC-486 (Oral Azacitidine) in Combination With Fulvestrant
NCT02374099 ·Status: TERMINATED ·Phase: PHASE2
-
A Study of the Body's Response to Exercise and a Plant-Based Diet in Overweight Postmenopausal Women With Breast Cancer
NCT04298086 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Biological Response to Tamoxifen (TAM) in Patients With Breast Cancer Non Metastatic RH+
NCT01220076 ·Status: COMPLETED ·Phase: PHASE2
-
Pharmacogenetics as a Predictor of Toxicity in Pre-Menopausal Women Receiving Doxorubicin and Cyclophosphamide in Early Breast Cancer
NCT00352872 ·Status: TERMINATED
-
An Examination of Predictors of Indicators of Response to Letrozole 2.5 mg
NCT00291109 ·Status: COMPLETED
-
Letrozole in Preventing Breast Cancer in Healthy Postmenopausal Women at High Risk for Breast Cancer
NCT01077453 ·Status: COMPLETED ·Phase: PHASE1
-
The Anti-tumor Effect of Metformin And Atorvastatin in Breast Cancer
NCT05507398 ·Status: UNKNOWN ·Phase: PHASE4
-
Electronic Study for Anastrozole Pharmacovigilance Evaluation
NCT00558168 ·Status: COMPLETED
-
Effect of Pharmacogenomics Differences in Phase I and II Metabolism of Tamoxifen on Efficacy and Toxicity
NCT00886535 ·Status: COMPLETED
-
An Investigation of the Effect of the Promoter Polymorphism in the Glucuronosyltransferase 2B7 in Patients on Breast Cancer Treatment
NCT00131612 ·Status: TERMINATED
-
Bexarotene in Preventing Breast Cancer in Women at Genetic Risk
NCT00055991 ·Status: COMPLETED ·Phase: PHASE1
-
Exemestane + Celecoxib vs Exemestane + Placebo in Metastatic Breast Cancer
NCT00525096 ·Status: COMPLETED ·Phase: PHASE3
-
Analyzing a New Mechanism in Response to Tamoxifen Therapy in Breast Cancer Patients
NCT01027416 ·Status: COMPLETED ·Phase: NA
-
Arzoxifene or Tamoxifen in Preventing Breast Cancer in Premenopausal Women at High Risk for Breast Cancer
NCT00253539 ·Status: COMPLETED ·Phase: PHASE2
-
Study of an eHealth Delivery Alternative for Cancer Genetic Testing for Hereditary Predisposition in Metastatic Cancer Patients
NCT04353973 ·Status: COMPLETED ·Phase: NA
-
Study of Cytochrome P450 Polymorphisms (CYP2D6, CYP3A4/5 and CYP2C19) in Breast Cancer Patients
NCT01169792 ·Status: COMPLETED
-
Letrozole in Preventing Breast Cancer in Postmenopausal Women
NCT00090857 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Breast Cancer Prevention by Letrozole in High Risk Women
NCT00579826 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of the Relationship of TOP2α Expression and Effect of Non Dose-dense Chemotherapy for Breast Cancer
NCT02506361 ·Status: RECRUITING